‹ ›
MYP_024393
← PREVIOUS NEXT → BACK
Basic Information
FP7
Antimicrobial
Antiviral
Antiviral ▸ Anti-Influenza virus ▸ Anti-Influenza A ▸ Anti-Influenza A virus
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
Standard
10 amino acids
C72H109N21O12
Standard
Sequence
RRKKIFYFFR
Physicochemical Analysis
1460.77 Da
11.73
4.76
4.55
0.4757
-0.97
0.29
-0.54
90.39
39.00
0.4000
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
583.19
-1.47
23.0
17.0
49.0
105.0
4.0
9.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0082029 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor
Influenza A virus (Virus entry); MDCK
0.15483 μM
Plaque assay
PaperA novel family of peptides with potent activity against influenza A viruses. | Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. | J Gen Virol. 2012 | PMID:22258859 PMID22258859 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/22258859/
RECORD: Rec_0087305 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-Influenza A virus Fusion inhibition
Influenza A virus A/WSN/33 H1N1 | MDCK cells
0.1548 μM
IC50
Mammalian: 1 h; Yeast: 2 min; E. coli: 2 min
PaperA novel family of peptides with potent activity against influenza A viruses. | Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. | J Gen Virol. 2012 May;93(Pt 5):980-986. | DOI:10.1099/vir.0.038679-0 | PMID:22258859 PMID22258859 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/22258859/
RECORD: Rec_0088687 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 22258859 PMID22258859 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/22258859/
RECORD: Rec_0144065 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 0.0%, E 0.0%, T 40.0%, C 60.0% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0374005 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
influenza A virus A/WSN/33 H1N1:inhibition of viral replication in MDCK cells
0.15483 μM
IC50
PaperPubMed PMID: 22258859 PMID22258859 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/22258859/